1. Home
  2. SFM vs NUVL Comparison

SFM vs NUVL Comparison

Compare SFM & NUVL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Sprouts Farmers Market Inc.

SFM

Sprouts Farmers Market Inc.

HOLD

Current Price

$79.41

Market Cap

6.9B

ML Signal

HOLD

Logo Nuvalent Inc.

NUVL

Nuvalent Inc.

HOLD

Current Price

$95.40

Market Cap

7.8B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
SFM
NUVL
Founded
2002
2017
Country
United States
United States
Employees
N/A
N/A
Industry
Food Chains
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Staples
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
6.9B
7.8B
IPO Year
2013
2021

Fundamental Metrics

Financial Performance
Metric
SFM
NUVL
Price
$79.41
$95.40
Analyst Decision
Buy
Strong Buy
Analyst Count
11
15
Target Price
$110.55
$135.33
AVG Volume (30 Days)
2.7M
441.5K
Earning Date
04-29-2026
05-07-2026
Dividend Yield
N/A
N/A
EPS Growth
41.60
N/A
EPS
5.31
N/A
Revenue
$8,806,159,000.00
N/A
Revenue This Year
$9.03
N/A
Revenue Next Year
$7.40
$1,064.25
P/E Ratio
$15.41
N/A
Revenue Growth
14.08
N/A
52 Week Low
$64.75
$55.54
52 Week High
$182.00
$113.02

Technical Indicators

Market Signals
Indicator
SFM
NUVL
Relative Strength Index (RSI) 54.36 37.55
Support Level $76.51 $73.22
Resistance Level $82.28 $107.13
Average True Range (ATR) 3.16 3.37
MACD 0.30 -0.48
Stochastic Oscillator 42.25 10.33

Price Performance

Historical Comparison
SFM
NUVL

About SFM Sprouts Farmers Market Inc.

Sprouts Farmers Market Inc offers a specialty grocery experience featuring an open layout with fresh produce at the heart of the store. Sprouts inspire wellness naturally with a carefully curated assortment products paired with purpose-driven people. The company continues to bring products made with lifestyle-friendly ingredients such as organic, plant-based, and gluten-free. It approximately has 407 stores in nearly 23 states. The Company has one operating segment that is healthy grocery stores.

About NUVL Nuvalent Inc.

Nuvalent Inc is a clinical-stage biopharmaceutical company focused on creating precisely targeted therapies for patients with cancer. All of its operations are in the United States. The company is engaged in developing small molecules that are designed to overcome the limitations of existing therapies for clinically validated kinase targets. The product candidates of the company include NVL-520, which is being developed for patients with ROS1-positive non-small cell lung cancer (NSCLC), NVL-655, which is being developed for patients with anaplastic lymphoma kinase (ALK)-positive NSCLC, NVL-330, is a brain-penetrant human epidermal growth factor receptor 2 (HER2)-selective inhibitor designed to address the combined medical need of treating tumors driven by HER2ex20.

Share on Social Networks: